BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SRP-1004 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SRP-1004\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06672445-10770@assetmemo.bio
DTSTAMP:20261121T005853Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:SRP-1004: Phase 1 readout est. (NCT06672445)
DESCRIPTION:SRP-1004\, phase 1\, Spinocerebellar Ataxia Type 2.\nStudy: Stu
 dy of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2\nEs
 timated primary completion: December 2026. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/srp-1004#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT06672445
URL:https://assetmemo.bio/drug/srp-1004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
